Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial.

Arthritis Res Ther · 2018 · PMC6282264 · PMID 30522501

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A numerically greater proportion of patients reported improvements ≥ MCID with abatacept versus placebo at week 16 in HAQ-DI scores, but the difference did not reach statistical significance (Fig. 4 a).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.